| 000 | 01080 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514161837.0 | ||
| 264 | 0 | _c20040322 | |
| 008 | 200403s 0 0 fre d | ||
| 022 | _a0248-8663 | ||
| 024 | 7 |
_a10.1016/s0248-8663(03)00249-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlicklé, J-F | |
| 245 | 0 | 0 |
_a[Type 2 diabetes mellitus pathogenesis: new therapeutic managements?]. _h[electronic resource] |
| 260 |
_bLa Revue de medecine interne _cNov 2003 |
||
| 300 |
_a709-10 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aCarbamates _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 | _aInsulin Secretion |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tLa Revue de medecine interne _gvol. 24 _gno. 11 _gp. 709-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0248-8663(03)00249-2 _zAvailable from publisher's website |
| 999 |
_c14342422 _d14342422 |
||